Hiroji Iwata

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 33

Top Topics

Physical Activity

Epidermal Growth Factor Receptor

Circulating Tumor

Metastatic Breast Cancer

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

JCO precision oncology

Breast cancer research and treatment

Breast cancer (Tokyo, Japan)

This page only lists publications with an associated author ORCID identifier.

Publications

Hiroji Iwata, Binghe Xu, Sung-Bae Kim, Wei-Pang Chung, Yeon Hee Park, Min Hwan Kim, Ling-Ming Tseng, Chi-Feng Chung, Chiun-Sheng Huang, Jee Hyun Kim, Joanne Wing Yan Chiu, Toshinari Yamashita, Wei Li, Anton Egorov, Soichiro Nishijima, Shunsuke Nakatani, Yuji Nishiyama, Masahiro Sugihara, Javier Cortés, Seock-Ah Im
Trastuzumab deruxtecan versus trastuzumab emtansine in Asian patients with HER2-positive metastatic breast cancer. Cancer science (2024)
Masaya Hattori, Victoria Serelli-Lee, Yoichi Naito, Takashi Yamanaka, Hiroyuki Yasojima, Rikiya Nakamura, Takao Fujisawa, Mitsuho Imai, Yoshiaki Nakamura, Hideaki Bando, Tsutomu Kawaguchi, Takayuki Yoshino, Hiroji Iwata
Genomic Landscape of Circulating Tumor DNA in Patients With Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor-2-Negative Metastatic Breast Cancer Treated With Abemaciclib: Data From the SCRUM-Japan Cancer Genome Screening Project. JCO precision oncology 8 (2024)
Masaya Hattori, Victoria Serelli-Lee, Yoichi Naito, Takashi Yamanaka, Hiroyuki Yasojima, Rikiya Nakamura, Takao Fujisawa, Mitsuho Imai, Yoshiaki Nakamura, Hideaki Bando, Tsutomu Kawaguchi, Takayuki Yoshino, Hiroji Iwata
Genomic Landscape of Circulating Tumor DNA in Patients With Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor-2-Negative Metastatic Breast Cancer Treated With Abemaciclib: Data From the SCRUM-Japan Cancer Genome Screening Project. JCO precision oncology 8 (2024)
Javier Cortes, Sara Alsterlind Hurvitz, Joyce O'Shaughnessy, Suzette Delaloge, Hiroji Iwata, Hope S Rugo, Patrick Neven, Dheepak Kanagavel, Patrick Cohen, Gautier Paux, Sylvaine Cartot-Cotton, Maya Stefanova-Urena, Laure Deyme, Jihane Aouni, Bernard Sebastien, Aditya Bardia
Randomized Phase III Study of Amcenestrant Plus Palbociclib Versus Letrozole Plus Palbociclib in Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Primary Results From AMEERA-5. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Masaya Hattori, Victoria Serelli-Lee, Yoichi Naito, Takashi Yamanaka, Hiroyuki Yasojima, Rikiya Nakamura, Takao Fujisawa, Mitsuho Imai, Yoshiaki Nakamura, Hideaki Bando, Tsutomu Kawaguchi, Takayuki Yoshino, Hiroji Iwata
Genomic Landscape of Circulating Tumor DNA in Patients With Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor-2-Negative Metastatic Breast Cancer Treated With Abemaciclib: Data From the SCRUM-Japan Cancer Genome Screening Project. JCO precision oncology 8 (2024)
Tadayoshi Hashimoto, Yoshiaki Nakamura, Takao Fujisawa, Mitsuho Imai, Taro Shibuki, Naoko Iida, Hiroshi Ozaki, Norio Nonomura, Chigusa Morizane, Hiroji Iwata, Susumu Okano, Wataru Yamagami, Naoya Yamazaki, Shigenori Kadowaki, Hiroya Taniguchi, Makoto Ueno, Shogen Boku, Eiji Oki, Yoshito Komatsu, Satoshi Yuki, Akitaka Makiyama, Tomoyuki Otsuka, Hiroki Hara, Naohiro Okano, Tomohiro Nishina, Yasutoshi Sakamoto, Izumi Miki, Shin Kobayashi, Junichiro Yuda, Shun-Ichiro Kageyama, Michiko Nagamine, Shingo Sakashita, Naoya Sakamoto, Riu Yamashita, Yoshikatsu Koga, Hideaki Bando, Genichiro Ishii, Takeshi Kuwata, Woong-Yang Park, Atsushi Ohtsu, Takayuki Yoshino
The SCRUM-MONSTAR Cancer-Omics Ecosystem: Striving for a Quantum Leap in Precision Medicine. Cancer discovery (2024)
Ayaka Isogai, Kazuki Nozawa, Akira Nakakami, Rie Komaki, Yuri Ozaki, Yuka Endo, Ayumi Kataoka, Haruru Kotani, Akiyo Yoshimura, Masaya Hattori, Masataka Sawaki, Hiroji Iwata
Clinical benefit of post-trastuzumab deruxtecan treatment in patients with HER 2-positive unresectable or metastatic breast cancer: A single-institution retrospective observational study. Breast cancer research and treatment 207 (2) (2024)
Javier Cortes, Sara Alsterlind Hurvitz, Joyce O'Shaughnessy, Suzette Delaloge, Hiroji Iwata, Hope S Rugo, Patrick Neven, Dheepak Kanagavel, Patrick Cohen, Gautier Paux, Sylvaine Cartot-Cotton, Maya Stefanova-Urena, Laure Deyme, Jihane Aouni, Bernard Sebastien, Aditya Bardia
Randomized Phase III Study of Amcenestrant Plus Palbociclib Versus Letrozole Plus Palbociclib in Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Primary Results From AMEERA-5. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (22) (2024)
Masaya Hattori, Victoria Serelli-Lee, Yoichi Naito, Takashi Yamanaka, Hiroyuki Yasojima, Rikiya Nakamura, Takao Fujisawa, Mitsuho Imai, Yoshiaki Nakamura, Hideaki Bando, Tsutomu Kawaguchi, Takayuki Yoshino, Hiroji Iwata
Genomic Landscape of Circulating Tumor DNA in Patients With Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor-2-Negative Metastatic Breast Cancer Treated With Abemaciclib: Data From the SCRUM-Japan Cancer Genome Screening Project. JCO precision oncology 8 (2024)
Akinobu Nakata, Naoya Hashimoto, Yukiya Narita, Munehiro Wakabayashi, Hiroyuki Kodama, Takatsugu Ogata, Kazunori Honda, Toshiki Masuishi, Hiroya Taniguchi, Shigenori Kadowaki, Masashi Ando, Yuka Endo, Haruru Kotani, Ayumi Kataoka, Masaya Hattori, Akiyo Yoshimura, Masataka Sawaki, Kazuki Nozawa, Isao Oze, Hiroji Iwata, Kei Muro
Safety of a short-term infusion of fosnetupitant in patients with gastrointestinal and breast cancer: a prospective study. The oncologist (2024)
Ayaka Isogai, Kazuki Nozawa, Akira Nakakami, Rie Komaki, Yuri Ozaki, Yuka Endo, Ayumi Kataoka, Haruru Kotani, Akiyo Yoshimura, Masaya Hattori, Masataka Sawaki, Hiroji Iwata
Clinical benefit of post-trastuzumab deruxtecan treatment in patients with HER 2-positive unresectable or metastatic breast cancer: A single-institution retrospective observational study. Breast cancer research and treatment (2024)
Masaya Hattori, Victoria Serelli-Lee, Yoichi Naito, Takashi Yamanaka, Hiroyuki Yasojima, Rikiya Nakamura, Takao Fujisawa, Mitsuho Imai, Yoshiaki Nakamura, Hideaki Bando, Tsutomu Kawaguchi, Takayuki Yoshino, Hiroji Iwata
Genomic Landscape of Circulating Tumor DNA in Patients With Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor-2-Negative Metastatic Breast Cancer Treated With Abemaciclib: Data From the SCRUM-Japan Cancer Genome Screening Project. JCO precision oncology 8 (2024)
Ian E Krop, Norikazu Masuda, Toru Mukohara, Shunji Takahashi, Takahiro Nakayama, Kenichi Inoue, Hiroji Iwata, Yutaka Yamamoto, Ricardo H Alvarez, Tatsuya Toyama, Masato Takahashi, Akihiko Osaki, Shigehira Saji, Yasuaki Sagara, Joyce O'Shaughnessy, Shoichi Ohwada, Kumiko Koyama, Tatsuya Inoue, Li Li, Parul Patel, Joseph Mostillo, Yoshimi Tanaka, David W Sternberg, Dalila Sellami, Kan Yonemori
Patritumab Deruxtecan (HER3-DXd), a Human Epidermal Growth Factor Receptor 3-Directed Antibody-Drug Conjugate, in Patients With Previously Treated Human Epidermal Growth Factor Receptor 3-Expressing Metastatic Breast Cancer: A Multicenter, Phase I/II Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Sherene Loi, Roberto Salgado, Thomas Powles, Javier Cortes, David W Cescon, Eric P Winer, Deborah L Toppmeyer, Hope S Rugo, Michelino De Laurentiis, Rita Nanda, Hiroji Iwata, Ahmad Awada, Antoinette R Tan, Yuan Sun, Vassiliki Karantza, Anran Wang, Lingkang Huang, Assieh Saadatpour, Razvan Cristescu, Jennifer Yearley, Jared Lunceford, Petar Jelinic, Sylvia Adams
Association Between Biomarkers and Clinical Outcomes of Pembrolizumab Monotherapy in Patients With Metastatic Triple-Negative Breast Cancer: KEYNOTE-086 Exploratory Analysis. JCO precision oncology 7 (2023)
Sherene Loi, Roberto Salgado, Thomas Powles, Javier Cortes, David W Cescon, Eric P Winer, Deborah L Toppmeyer, Hope S Rugo, Michelino De Laurentiis, Rita Nanda, Hiroji Iwata, Ahmad Awada, Antoinette R Tan, Yuan Sun, Vassiliki Karantza, Anran Wang, Lingkang Huang, Assieh Saadatpour, Razvan Cristescu, Jennifer Yearley, Jared Lunceford, Petar Jelinic, Sylvia Adams
Association Between Biomarkers and Clinical Outcomes of Pembrolizumab Monotherapy in Patients With Metastatic Triple-Negative Breast Cancer: KEYNOTE-086 Exploratory Analysis. JCO precision oncology 7 (2023)
Sara M Tolaney, Arlene Chan, Katarina Petrakova, Suzette Delaloge, Mario Campone, Hiroji Iwata, Parvin F Peddi, Peter A Kaufman, Elisabeth De Kermadec, Qianying Liu, Patrick Cohen, Gautier Paux, Lei Wang, Nils Ternès, Eric Boitier, Seock-Ah Im
AMEERA-3: Randomized Phase II Study of Amcenestrant (Oral Selective Estrogen Receptor Degrader) Versus Standard Endocrine Monotherapy in Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Hiroji Iwata, Yutaka Yamamoto, Takehiko Sakai, Yoshie Hasegawa, Rikiya Nakamura, Hiromitsu Akabane, Shoichiro Ohtani, Masahiro Kashiwaba, Naruto Taira, Tatsuya Toyama, Tomomi Fujisawa, Norikazu Masuda, Yukiko Shibahara, Hironobu Sasano, Takuhiro Yamaguchi
Phase III study of long-term prognosis of estrogen receptor-positive early breast cancer treated with neoadjuvant endocrine therapy with/without adjuvant chemotherapy. Breast cancer research and treatment (2023)
Daiki Takatsuka, Akiyo Yoshimura, Masataka Sawaki, Masaya Hattori, Haruru Kotani, Ayumi Kataoka, Nanae Horisawa, Yuri Ozaki, Yuka Endo, Kazuki Nozawa, Hiroji Iwata
Evaluation of the Role of Axillary Lymph Node Fine-Needle Aspiration Cytology in Early Breast Cancer With or Without Neoadjuvant Chemotherapy. Journal of breast cancer (2023)
Kenji Tamura, Toru Mukohara, Kan Yonemori, Yumiko Kawabata, Xavier Nicolas, Tomoyuki Tanaka, Hiroji Iwata
Phase 1 study of oral selective estrogen receptor degrader (SERD) amcenestrant (SAR439859), in Japanese women with ER-positive and HER2-negative advanced breast cancer (AMEERA-2). Breast cancer (Tokyo, Japan) (2023)
Nicholas C Turner, Cynthia Huang-Bartlett, Kevin Kalinsky, Massimo Cristofanilli, Giampaolo Bianchini, Stephen K L Chia, Hiroji Iwata, Wolfgang Janni, Cynthia X Ma, Erica L Mayer, Jang-Yeon Park, Steven Fox, Xiaochun Liu, Sasha McClain, Francois-Clement Bidard
Design of SERENA-6, a phase III switching trial of camizestrant in ESR1 -mutant breast cancer during first-line treatment. Future oncology (London, England) (2023)
Pfeiler Georg, Dominik Hlauschek, Erica L Mayer, Christine Deutschmann, Stephanie Kacerovsky-Strobl, Miguel Martin, Jane Lowe Meisel, Nicholas Zdenkowski, Sibylle Loibl, Marija Balić, Haeseong Park, Aleix Prat, Claudine Isaacs, Emilio Bajetta, Justin M Balko, Merixtell Bellet-Ezquerra, Judith M Bliss, Harold J Burstein, Fatima Cardoso, Hannes Fohler, Theodoros Foukakis, Karen A Gelmon, Matthew P Goetz, Tufia C Haddad, Hiroji Iwata, Jacek Jassem, Soo-Chin Lee, Barbro Linderholm, Maartje Los, Eleftherios P P Mamounas, Kathy D Miller, Patrick G Morris, Elisabetta Munzone, Einav Nili Gal-Yam, Alistair Ring, Lois E Shepherd, Christian F Singer, Christoph Thomssen, Ling Ming Tseng, Pinuccia Valagussa, Eric P Winer, Antonio C Wolff, Francesco Ravera, Jana Machacek-Link, Céline Schurmans, Xin Huang, Eric Gauthier, Christian Fesl, Amylou C Dueck, Angela M DeMichele, Michael Gnant, null null
Impact of BMI in Patients With Early Hormone Receptor-Positive Breast Cancer Receiving Endocrine Therapy With or Without Palbociclib in the PALLAS Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Erica L Mayer, Christian Fesl, Dominik Hlauschek, Laura Garcia-Estevez, Harold J Burstein, Nicholas Zdenkowski, Viktor Wette, Kathy D Miller, Marija Balic, Ingrid A Mayer, David A Cameron, Eric P Winer, José Juan Ponce Lorenzo, Diana Lake, Gunda Pristauz-Telsnigg, Tufia C Haddad, Lois Shepherd, Hiroji Iwata, Matthew P Goetz, Fatima Cardoso, Tiffany A Traina, Dhanusha Sabanathan, Urs Breitenstein, Kerstin Ackerl, Otto Metzger Filho, Karin Zehetner, Kadine Solomon, Sarra El-Abed, Kathy Puyana Theall, Dongrui Ray Lu, Amylou C Dueck, Michael Gnant, Angela M DeMichele
Treatment Exposure and Discontinuation in the PALbociclib CoLlaborative Adjuvant Study of Palbociclib With Adjuvant Endocrine Therapy for Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer (PALLAS/AFT-05/ABCSG-42/BIG-14-03). Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (5) (2022)
Leisha A Emens, Luciana Molinero, Sherene Loi, Hope S Rugo, Andreas Schneeweiss, Véronique Diéras, Hiroji Iwata, Carlos H Barrios, Marina Nechaeva, Anh Nguyen-Duc, Stephen Y Chui, Amreen Husain, Eric P Winer, Sylvia Adams, Peter Schmid
Atezolizumab and nab-Paclitaxel in Advanced Triple-Negative Breast Cancer: Biomarker Evaluation of the IMpassion130 Study. Journal of the National Cancer Institute 113 (8) (2022)
Kazuki Nozawa, Masaya Hattori, Akiyo Yoshimura, Hiroji Iwata
Clinical Utility of Precision Medicine in Early Breast Cancer: What Is the Optimal Framework to Develop Precision Medicine? Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (17) (2022)
Massimo Cristofanilli, Hope S Rugo, Seock-Ah Im, Dennis J Slamon, Nadia Harbeck, Igor Bondarenko, Norikazu Masuda, Marco Colleoni, Angela DeMichele, Sherene Loi, Hiroji Iwata, Ben O'Leary, Fabrice Andre, Sibylle Loibl, Eustratios Bananis, Yuan Liu, Xin Huang, Sindy Kim, Maria Jose Lechuga Frean, Nicholas C Turner
Overall Survival with Palbociclib and Fulvestrant in Women with HR+/HER2- ABC: Updated Exploratory Analyses of PALOMA-3, a Double-blind, Phase III Randomized Study. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (16) (2022)
Tatsuo Akechi, Takuhiro Yamaguchi, Megumi Uchida, Fuminobu Imai, Kanae Momino, Fujika Katsuki, Naomi Sakurai, Tempei Miyaji, Tomoe Mashiko, Masaru Horikoshi, Toshi A Furukawa, Akiyo Yoshimura, Sumito Saeki, Natsue Uehiro, Kenji Higaki, Yoshie Hasegawa, Kazuhisa Akahane, Yosuke Uchitomi, Hiroji Iwata
Smartphone Psychotherapy Reduces Fear of Cancer Recurrence Among Breast Cancer Survivors: A Fully Decentralized Randomized Controlled Clinical Trial (J-SUPPORT 1703 Study). Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Naruto Taira, Masataka Sawaki, Yukari Uemura, Tsuyoshi Saito, Shinichi Baba, Kokoro Kobayashi, Hiroaki Kawashima, Michiko Tsuneizumi, Noriko Sagawa, Hiroko Bando, Masato Takahashi, Miki Yamaguchi, Tsutomu Takashima, Takahiro Nakayama, Masahiro Kashiwaba, Toshiro Mizuno, Yutaka Yamamoto, Hiroji Iwata, Yasuo Ohashi, Hirofumi Mukai, Takuya Kawahara, null null
Health-Related Quality of Life With Trastuzumab Monotherapy Versus Trastuzumab Plus Standard Chemotherapy as Adjuvant Therapy in Older Patients With HER2-Positive Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (22) (2021)
Yoichi Shimizu, Katsunori Tsuji, Eisuke Ochi, Ryo Okubo, Aya Kuchiba, Taichi Shimazu, Noriatsu Tatematsu, Naomi Sakurai, Hiroji Iwata, Yutaka J Matsuoka
Oncology care providers' awareness and practice related to physical activity promotion for breast cancer survivors and barriers and facilitators to such promotion: a nationwide cross-sectional web-based survey. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer (2021)
Eva Maria Ciruelos, Hope S Rugo, Ingrid A Mayer, Christelle Levy, Frédéric Forget, Juan Ignacio Delgado Mingorance, Tamar Safra, Norikazu Masuda, Yeon Hee Park, Dejan Juric, PierFranco Conte, Mario Campone, Sibylle Loibl, Hiroji Iwata, Xiaolei Zhou, Jinhee Park, Antonia Ridolfi, Ines Lorenzo, Fabrice Andre
Patient-Reported Outcomes in Patients With PIK3CA-Mutated Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer From SOLAR-1. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (18) (2021)
Haruru Kotani, Mitsuo Terada, Makiko Mori, Nanae Horisawa, Kayoko Sugino, Ayumi Kataoka, Yayoi Adachi, Naomi Gondou, Akiyo Yoshimura, Masaya Hattori, Masataka Sawaki, Chihoko Takahata, Makiko Kobara, Hiroji Iwata
Compression therapy using surgical gloves does not prevent paclitaxel-induced peripheral neuropathy: results from a double-blind phase 2 trial. BMC cancer 21 (1) (2021)
Junji Tsurutani, Hiroji Iwata, Ian Krop, Pasi A Jänne, Toshihiko Doi, Shunji Takahashi, Haeseong Park, Charles Redfern, Kenji Tamura, Trisha M Wise-Draper, Kaku Saito, Masahiro Sugihara, Jasmeet Singh, Takahiro Jikoh, Gilles Gallant, Bob T Li
Targeting HER2 with Trastuzumab Deruxtecan: A Dose-Expansion, Phase I Study in Multiple Advanced Solid Tumors. Cancer discovery 10 (5) (2020)
Hiroji Iwata, Shigehira Saji, Masahiko Ikeda, Masashi Inokuchi, Takayoshi Uematsu, Tatsuya Toyama, Rie Horii, Chikako Yamauchi
The Japanese Breast Cancer Society Clinical Practice Guidelines, 2018 edition: the tool for shared decision making between doctor and patient. Breast cancer (Tokyo, Japan) 27 (1) (2019)
Hiroji Iwata, Norikazu Masuda, Yutaka Yamamoto, Tomomi Fujisawa, Tatsuya Toyama, Masahiro Kashiwaba, Shoichiro Ohtani, Naruto Taira, Takehiko Sakai, Yoshie Hasegawa, Rikiya Nakamura, Hiromitsu Akabane, Yukiko Shibahara, Hironobu Sasano, Takuhiro Yamaguchi, Kentaro Sakamaki, Helen Bailey, Diana B Cherbavaz, Debbie M Jakubowski, Naoko Sugiyama, Calvin Chao, Yasuo Ohashi
Validation of the 21-gene test as a predictor of clinical response to neoadjuvant hormonal therapy for ER+, HER2-negative breast cancer: the TransNEOS study. Breast cancer research and treatment 173 (1) (2018)